After announcing its Jersey-based joint venture to supply Europe and United Kingdom last week, the Canadian-based company introduces its “down-under” distribution partner.
Toronto, March 2, 2020/ Chair & CEO Diane Scott announced today that JMCC Group has signed an agreement with Sativite Pty to distribute JMCC medical cannabis products throughout Australia, New Zealand and other countries in the region.
The deal follows the announcement of another last week on the formation of JMCC European Distribution Limited in the Channel Island of Jersey to expedite medical cannabis deliveries to Europe and the United Kingdom. The new partnership extends the company’s
self-managed supply chain to ensure plant-to-patient control over product quality, safety and security for patients and business customers in Australasia.
JMCC is the only Canadian private medical cannabis company to own its entire supply chain.
“We have been focused on creating a fully integrated medical cannabis company and determining how to expand our distribution network was the final step. Having served the Australian market from Toronto for the past few years, it was clear that our growth required us to think differently. This partnership is a perfect addition to our model for reaching patients worldwide,” said Ms. Scott.
Ms. Scott initially met some of the founders of what was to become Sativite Pty three years ago at Toronto’s Lift Conference & Expo, and says she is thrilled the long relationship had finally culminated in the opportunity to work more closely together. One of those founders was Brian White, now a Director and Chief Technical Officer with Sativite.
“You could call it a long courtship, “Mr. White said. “From the start, we were interested in doing business with JMCC in some way as our values are so well aligned. The stars finally aligned too and we’re delighted to now be representing JMCC in this part of the world.”
Sativite CEO Mike Cleary said he’s excited his company was selected to distribute JMCC’s products to countries throughout the region that have legalized cannabis for medicinal use.
“As patients ourselves, the entire executive team is committed to delivering the most highquality and affordable medicinal cannabis products available from Australia and around the world to pharmacies and patients in the region. This partnership enables us to add pharmagrade, Jamaican products to our offering, and from a company that is as passionate about quality, safety and sustainability as we are.”
About JMCC Group
Headquartered in Toronto, Canada, JMCC Group is a fully integrated medical cannabis company, operating within a self-contained supply chain – from propagation and cultivation of raw material supply, product development, manufacturing and packaging, and through to global logistics and distribution. Founded in 2016, today, JMCC is the leading global provider of premium Jamaican medical cannabis products and services to the world. Learn more at www.jamaicanmedicann.com.
About Sativite Pty
Headquartered in Bellbowrie, near Brisbane, Queensland, Sativite is a licensed medical cannabis wholesaler. We seek out, import and distribute the best cannabis – selected varieties of high-quality, organically and sustainably grown dried flower and broad-spectrum extracts with a range of cannabinoid profiles, as well as the best cannabis-based medicines and delivery devices we can find from leading licensed suppliers worldwide. We also offer a growing line of Sativite-branded, CBD-rich prescription products available through pharmacies and our own on-line pharmacy. Learn more at www.sativite.com.au.
For more information, contact:
Global Director, Marketing & Communications
T: 416 272 8981
Chief Executive Officer
M: +61 (0) 427 978 915
Global Public Affairs
T: +1 416 797 8194